News, reviews and podcasts from annual scientific meetings and symposiums around the world.
When it comes to radiation therapy to treat brain cancer, hippocampal-avoidance whole-brain radiotherapy in conjunction…
In the first randomized, phase II clinical trial of its kind, researchers have shown that…
Men and women may need to be treated differently – at least when it comes…
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including…
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower…
Nearly one in six premenopausal women being treated for early stage breast cancer do not…
Epigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced…
Treatment with the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib achieves a clinically meaningful improvement…
Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking…
Targeting a common mutation in patients with hormone receptor positive (HR ) HER2 negative (HER2-)…